BTG plc (LON:BTG)‘s stock had its “buy” rating reiterated by stock analysts at Deutsche Bank AG in a research report issued on Friday.
A number of other equities analysts also recently commented on the stock. Stifel Nicolaus downgraded shares of BTG plc to a “hold” rating in a research note on Thursday, July 14th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a GBX 790 ($9.78) price target on shares of BTG plc in a research report on Tuesday, August 16th. Numis Securities Ltd reaffirmed a “hold” rating and set a GBX 737 ($9.12) price target on shares of BTG plc in a research report on Thursday, October 6th. Finally, Jefferies Group upped their price target on BTG plc from GBX 840 ($10.40) to GBX 860 ($10.64) and gave the stock a “buy” rating in a research report on Wednesday, June 29th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of GBX 799.57 ($9.90).
BTG plc (LON:BTG) opened at 698.50 on Friday. The stock’s market capitalization is GBX 2.67 billion. BTG plc has a 52-week low of GBX 504.00 and a 52-week high of GBX 739.50. The company’s 50-day moving average price is GBX 631.14 and its 200 day moving average price is GBX 641.59.
In related news, insider Soderstrom,Rolf sold 74,327 shares of the company’s stock in a transaction on Thursday, July 21st. The stock was sold at an average price of GBX 676 ($8.37), for a total value of £502,450.52 ($621,844.70).
BTG plc Company Profile
BTG plc is engaged in the business of healthcare, focusing on Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care uses, and a licensing business. The Company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and Licensing.
Receive News & Ratings for BTG plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG plc and related companies with MarketBeat.com's FREE daily email newsletter.